Haematologica (May 2019)
Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort
- Maria Winqvist,
- Per-Ola Andersson,
- Anna Asklid,
- Karin Karlsson,
- Claes Karlsson,
- Birgitta Lauri,
- Jeanette Lundin,
- Mattias Mattsson,
- Stefan Norin,
- Anna Sandstedt,
- Richard Rosenquist,
- Florentin Späth,
- Lotta Hansson,
- Anders Österborg,
- for the Swedish CLL Group
Affiliations
- Maria Winqvist
- Department of Hematology, Karolinska University Hospital, Stockholm;Department of Oncology-Pathology, Karolinska Institutet, Stockholm
- Per-Ola Andersson
- Department of Hematology, Borås Hospital
- Anna Asklid
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm
- Karin Karlsson
- Department of Hematology, Lund University Hospital
- Claes Karlsson
- Department of Hematology, Karolinska University Hospital, Stockholm;Department of Oncology-Pathology, Karolinska Institutet, Stockholm
- Birgitta Lauri
- Department of Hematology, Sunderby Hospital, Sunderbyn-Luleå
- Jeanette Lundin
- Department of Hematology, Karolinska University Hospital, Stockholm;Department of Oncology-Pathology, Karolinska Institutet, Stockholm
- Mattias Mattsson
- Department of Hematology, Uppsala University Hospital
- Stefan Norin
- Department of Internal Medicine, Karolinska Institutet, Stockholm
- Anna Sandstedt
- Department of Hematology, Linköping University Hospital
- Richard Rosenquist
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm
- Florentin Späth
- Department of Radiation Sciences, Oncology, Umeå University, Sweden
- Lotta Hansson
- Department of Hematology, Karolinska University Hospital, Stockholm;Department of Oncology-Pathology, Karolinska Institutet, Stockholm
- Anders Österborg
- Department of Hematology, Karolinska University Hospital, Stockholm;Department of Oncology-Pathology, Karolinska Institutet, Stockholm
- for the Swedish CLL Group
- DOI
- https://doi.org/10.3324/haematol.2018.198820
- Journal volume & issue
-
Vol. 104,
no. 5
Abstract
No abstracts available.